Suggestions appear as you type. Use the up and down arrows to choose one and Enter to open it.

This page's audience our own tag's counts — open to see them
–Visits
–Page views
–Clicks to vendors
–Time on page
–Reading now
Clicks to vendors, by tool
  • –
Top countries
  • –
Devices
  • –

– · visits, page views and clicks counted by our own tag, which counts more than our checked analytics; every figure rounded down · how we count

Embarke review

Freemium#12 of 28 in AI Research Assistants

A controlled AI workflow for systematic reviews, evidence synthesis, and living updates.

8.1/10Editor score
Embarke8.1 Visit Embarke

Reviewed by iTechGuides Editors · Editorial team · Updated Oct 2026

Embarke is an AI research and evidence-synthesis platform for medical writers, regulatory teams, and health technology assessment professionals. It supports quick evidence discovery, systematic synthesis, scoping reviews, and scheduled living-synthesis updates. Its multi-agent workflow assigns Scout, Analyst, Writer, Critic, and Calibrator roles across source discovery, analysis, drafting, critique, and calibration. The platform is available on the web and as a self-hosted option, with DOCX, PDF, and Markdown exports.

Methodological controls are the main reason to consider Embarke. Its outputs align with PRISMA 2020, while GRADE-informed certainty estimates add a structured view of evidence certainty. Retraction-aware citation checking, methodology stamps, and risk-of-bias assessment using RoB 2, ROBINS-I, AMSTAR 2, and QUADAS-2 support evidence-focused workflows. Signed reproducibility ZIP exports and scheduled reruns extend the product beyond one-off research briefs, particularly for teams maintaining living syntheses.

The published plans show a useful entry point, but the paid tiers define the broader workflow. Free includes three PRISMA-light reviews per month, unlimited Discover, Tier-1 sources, and watermarked outputs. Plus costs $39 per month and adds unlimited briefs, unlimited PRISMA-light reviews, and GRADE-informed certainty estimates. Team costs $399 per month and includes up to five seats, a shared workspace, and a peer-review workflow. Embarke suits teams that need methodological structure, review controls, and reproducibility packages; a simpler research tool may be a better fit for users who do not need these controls or collaborative review features.

Embarke pros and cons

  • Where it wins
    • PRISMA 2020-aligned outputs with GRADE-informed certainty estimates
    • Risk-of-bias checks across RoB 2, ROBINS-I, AMSTAR 2, and QUADAS-2
    • Signed reproducibility exports plus scheduled living-synthesis reruns
  • Where it doesn't
    • Free plan limits PRISMA-light reviews to three per month
    • Free outputs are watermarked
    • Plus costs $39 per month; Team costs $399 per month

Embarke fact sheet, pricing and score →

Advertiser disclosure: iTechGuides is reader-supported. Vendors can pay for top positions in our rankings and for a place on other products' pages, and we may earn a commission when you click some links. Bought places stand at the number bought; this page and our disclosure say so. Paying vendors may get a fuller, more detailed review from our editors, and that review can change their score. How we rank.

Last updated · How we research and update